Screenshot 2024-02-20 at 15.04.00
Bitcoin Well Provides Preliminary Year End Update and Bitcoin Super Company Vision
February 21, 2024 08:35 ET | Bitcoin Well
Preliminary, unaudited Q4 growth numbers for Bitcoin Well and Bitcoin Super Company vision outline.
ONL logo.jpg
ONL Therapeutics to Present at 2024 BIO CEO & Investor Conference
February 06, 2024 07:00 ET | ONL Therapeutics
ANN ARBOR, Mich., Feb. 06, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
roche-logo-blue.png
New long-term data for Roche’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)
February 01, 2024 01:03 ET | F. Hoffmann-La Roche Ltd
Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry vision Up to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months...
ONL logo.jpg
ONL Therapeutics to Present on ONL1204 in Podium Presentation at the 47th Annual Meeting of the Macula Society
January 23, 2024 07:00 ET | ONL Therapeutics
ANN ARBOR, Mich., Jan. 23, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
Morgan Gustafson Pro
Morgan Gustafson Promoted to Jr. Art Director at Hummingbird Creative Group
January 16, 2024 15:37 ET | Hummingbird Creative Group
Cary, North Carolina, USA, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Hummingbird Creative Group, a brand strategy and creative agency in Cary, North Carolina, announced the promotion of Morgan Gustafson to...
NMDP-BTM_Dual_2_Color_BlueGreen_Logo_RGB_2000x542 (1).png
Be The Match Raises $1.1 Million at Annual Gala
October 05, 2023 09:18 ET | Be The Match
Be The Match celebrated its 16th annual fundraising Gala in Minneapolis on September 30 and raised $1.1 million.
cmi_logo.png
[Latest] Global Pulp and Paper Automation Market Size/Share Worth USD 12.4 Billion by 2032 at a 6.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
October 02, 2023 17:30 ET | Custom Market Insights
Austin, TX, USA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Pulp and Paper Automation Market Size, Trends and Insights By Product...
RetinalGeniX Logo Revised Sept 2023.jpg
RetinalGeniX Technologies Inc. Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases
September 18, 2023 05:59 ET | RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) released to the public via OTC Markets, a video webinar regarding...
Neuromeka’s booth at FABTECH 2023
Neuromeka Participates in FABTECH 2023, Unveiling 3D Vision Collaborative Robot Welding Solution
September 13, 2023 18:45 ET | Neuromeka USA, Inc.
CHICAGO, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Neuromeka unveiled its collaborative robot welding solution during FABTECH 2023, North America's largest metal forming, fabricating, welding and finishing...
ONL logo.jpg
ONL Therapeutics Completes Enrollment in Phase 2 Study of First-in-Class Fas-Inhibitor in Patients with Macula-Off Rhegmatogenous Retinal Detachment
August 28, 2023 07:00 ET | ONL Therapeutics
More than 135 patients recruited in four months for Phase 2 study of a single intravitreal (IVT) injection of ONL1204 Ophthalmic Solution as adjunct to standard-of-care surgery Topline data readout...